Cimpress price target raised to $50 from $45 at Truist

Truist analyst Youssef Squali raised the firm’s price target on Cimpress to $50 from $45 and keeps a Buy rating on the shares. The firm is incrementally positive on Cimpress following Friday’s mid-year update, as the firm believes Cimpress is back to steadier growth of mid-to- high-single-digit rate with double-digit growth in the bottom line, owing to material margin improvement from stricter cost containment, the analyst tells investors in a research note.